Potential Clients & Partnerships

We are pursuing a variety of stakeholders and pilot opportunities, particularly focusing on NYC or Boston-based organizations during our market entry.

Pharmaceutical & Biotechnology

• Pfizer (NYC)
• Bristol Myers Squibb (NYC)
• Biogen (Boston)
• Vertex (Boston)
• Novartis (Cambridge)
• Sanofi (Cambridge)
• Takeda (Cambridge)

Payers & Insurers

• Empire BlueCross BlueShield (NYC)
• Oscar Health (NYC)
• UnitedHealthcare (NYC presence)
• EmblemHealth (NYC)
• Blue Cross Blue Shield of Massachusetts
• Point32Health (Harvard Pilgrim and Tufts Health Plan)
• Healthfirst (New York)
• MassHealth (Massachusetts)

Hospitals & Health Systems

• Mount Sinai (NYC)
• NewYork-Presbyterian (NYC)
• Northwell Health (NYC area)
• Mass General Brigham (Boston)
• Dana-Farber Cancer Institute (Boston)
• Beth Israel Lahey Health (Massachusetts)

HEOR Consultancies & Research Organizations

• Analysis Group (Boston/NYC)
• Precision Value & Health
• IQVIA
• ICON Plc
• Evidera
• OPEN Health

Government & Public Health Organizations

City & State Health Departments

• NYC Department of Health and Mental Hygiene (DOHMH)
• NYC Health + Hospitals (H+H)
• New York State Department of Health (NYSDOH)

Federal Agencies

• Centers for Medicare & Medicaid Services (CMS)
• Centers for Disease Control and Prevention (CDC)

Non-Profit & NGO Partners

• World Health Organization (WHO)
• Bill & Melinda Gates Foundation
• UNICEF

Academic & Public Health

• Columbia University Mailman School of Public Health (NYC)
• NYU School of Global Public Health (NYC)
• CUNY School of Public Health (NYC)
• Harvard T.H. Chan School of Public Health (Boston)
• Boston University School of Public Health